JetBlue Airways Corporation vs NeoGenomics Inc. Common Stock — how do they compare? JetBlue Airways Corporation trades at $3.01 (market cap $1.13B), while NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B). The key difference: NeoGenomics Inc. Common Stock is the larger of the two by market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JetBlue Airways Corporation for 44 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| JBLU | NEO | |
|---|---|---|
Market Cap | $1.13B | $2.17B |
Volume | 40,474,891 | 1,615,943 |
Sector | Industrials | Health |
52-Week High | $6.46 | $19.91 |
52-Week Low | $3.01 | $7.19 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | $8.50B | $2.47B |
Signals from Pluang's Aura AI — not financial advice
JetBlue Airways (JBLU) trades at $3.35, down 7.46% in the last session, reflecting ongoing challenges in the airline sector. The stock shows bearish technical signals with mixed fundamentals - while valuation ratios like P/S (0.12) and P/B (0.71) appear attractive, the company continues to report negative earnings with a -9.32% net income margin. Recent developments include route expansion to Colombia and the launch of BlueFirst premium seating, though fuel cost pressures and capacity adjustments remain headwinds.
The investment outlook remains cautious given persistent losses and high debt levels (51.28% debt-to-asset ratio). While analyst consensus suggests 62% upside to the $5.89 price target, execution risks and industry volatility warrant careful consideration. The key opportunity lies in operational turnaround potential, but investors face significant exposure to fuel prices and competitive pressures in the crowded airline market.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →